Loading...
Enhancing The Bystander Killing Effect Of An Oncolytic HSV By Arming It With A Secretable Apoptosis Activator
Although oncolytic viruses have shown great promise as cancer therapeutics, results from a recent phase III clinical trial indicate that their potency may need further improvement for a clear clinical benefit. Here, we report a novel strategy to increase the bystander effect of virotherapy by arming...
Na minha lista:
| Udgivet i: | Gene Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4352111/ https://ncbi.nlm.nih.gov/pubmed/25567538 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/gt.2014.113 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|